GSA CAPITAL PARTNERS LLP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 115 filers reported holding INTERSECT ENT INC in Q3 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$364,000
-17.8%
13,013
-52.1%
0.05%
-33.8%
Q3 2020$443,000
-10.9%
27,171
+53.9%
0.07%
+29.8%
Q4 2018$497,000
-36.2%
17,651
-34.8%
0.06%
+32.6%
Q3 2018$779,000
-41.7%
27,084
-24.1%
0.04%
-34.8%
Q2 2018$1,336,000
+496.4%
35,680
+527.0%
0.07%
+450.0%
Q1 2018$224,000
-85.3%
5,691
-87.9%
0.01%
-87.0%
Q4 2017$1,520,000
+64.1%
46,906
+57.8%
0.09%
+46.0%
Q3 2017$926,00029,7340.06%
Other shareholders
INTERSECT ENT INC shareholders Q3 2020
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders